Cargando…
Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers
Many types of drugs and agents used for cancer diagnosis and therapy often have low bioavailability and insufficient efficacy, as well as causing various side effects due to their nonspecific delivery. Nanocarriers with purposely-designed compositions and structures have shown varying degrees of abi...
Autores principales: | Tan, Ronghua, Wan, Ying, Yang, Xiangliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Multimedia Press Co., Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255820/ https://www.ncbi.nlm.nih.gov/pubmed/35837654 http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.005 |
Ejemplares similares
-
Colloidal hydroxyethyl starch for tumor-targeted platinum delivery
por: Xiao, Chen, et al.
Publicado: (2018) -
Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy
por: Tan, Ronghua, et al.
Publicado: (2021) -
Preparation and characterization of 2-hydroxyethyl starch microparticles for co-delivery of multiple bioactive agents
por: Obireddy, Sreekanth Reddy, et al.
Publicado: (2021) -
Hydroxyethyl Starch-Based Nanoparticles Featured with Redox-Sensitivity and Chemo-Photothermal Therapy for Synergized Tumor Eradication
por: Yu, Chan, et al.
Publicado: (2019) -
Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)